Auriga Research

Leading Indian CRO

  • Home
    • About Us
    • Arbro Group
  • Testing Services
    • Pharmaceutical Testing
    • Food Testing
    • Herbal Testing
    • Cosmetics Testing
    • Medical Device Testing
    • Water Testing
    • Sensory Analysis
    • Inspection & Sampling
    • Construction & Building Material Testing Lab
    • Shelf Life Studies
  • Analytical Research
    • Characterization
    • Method Development
    • Method Validation
    • Stability studies
    • Impurity Profiling
    • Routine Analysis
  • Clinical Trials
    • Clinical Trial Regulation in India: Recent Updates
    • Feasibility Studies
    • Cosmetic Clinical Trial
    • Medical Writing
    • Investigator Selection
    • Project Management
    • Site Management
    • Monitoring
    • Clinical Trial Formulation
      • Clinical Trial Services (Phase I to IV)
    • Laboratory Services
      • Accomplishments
  • Bioequivalence Studies
    • Bioavailability & Bioequivalences Studies
    • Bioanalytical Methods
    • Clinical Facilities
    • Project Management
    • Medical Writing
    • Regulatory Assistance
    • Biowaiver Monograph
    • RLD Sourcing
    • Volunteers with us
  • Free E-courses
    • Ethics Committee Accreditation and Registration in India
    • Analytical Training
    • Free E-Course on Bio-Equivalence Studies
    • New Drug Approval in India: A free online course
    • Free e-Course : Regulation on Medical Devices and Diagnostic Kits in India
  • News
    • Workshops
    • Conference on Challenges in Design and Conduct of Clinical Trials of Medical Devices
  • Contact Us
    • Current Openings
    • Business Queries
    • Investigator Registration
    • Partnering With Us
You are here: Home / Clinical Trial / Monitoring

Monitoring

Monitoring is very important aspect of trial. The monitor is the main communication link between the Sponsor and the Investigator. In very simple understandable language Monitoring is the Act of overseeing  progress of a clinical trial and ensuring that it is conducted, recorded and reported in accordance with protocol, SOPs, GCPs and applicable regulatory requirements.

Auriga has well experienced team of Monitors/CRAs and we have the flexibility of working with the monitors appointed by Sponsor CRAs/Monitors. Monitors at Auriga are well trained and experienced with the stages of a Monitoring Visit & advance planning.

For outsourced monitoring services Auriga can be broadly categorized in four types of Site Visits

  1. Site Assessment (Pre-study) Visit is to evaluate site’s / investigator’s resources and capabilities to conduct a research study in term of Site infrastructure, Adequacy and availability of site facilities for study conduct.
  2. Site Initiation Visit is planned to uniformly provide study-specific information to investigator(s) and staff prior to study start-up and reassess resources and capability to conduct a research study. The monitor will also discuss with the clinical staff about research obligations as per GCP. The monitor will also provide necessary guidance to the site as determined by his/her findings.
  3. Interim Monitoring Visit is planned to assess the progress of trial in terms ofAccuracy, completeness and verification of reported trial data. Majorly monitor will review Study Product Accountability, review of Protocol-Specific Record, CRF review, assessment of Laboratory.
  4. Close out Site Visit is planned after study completion/withdrawal. The monitor will submit the final report submitted to IRB/IEC and sponsor. The monitor will obtain copies of all study product shipping, receiving, and accountability records for submission to sponsor.

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Quick Query

News

  • Auriga Research invites you to CPhI China from 20 – 22 June 2017 SNIEC, Shanghai, China
  • Ethics Committee Accreditation and Registration in India: Introduction
  • DTAB recommends not using vegetarian indicator on cellulose capsules and prohibits use of PET bottles for packaging pharmaceutical drugs
  • A report by AIIH&PH on the use of PET or plastic bottles for packaging of pharmaceutical preparations, soft drinks and alcohol
  • Arbro Pharma & Auriga Research Exhibiting in ASIA LABEX 2015
  • Conference on Challenges in Design and Conduct of Clinical Trials of Medical Devices
  • Great News! Auriga BE Center is now approved by NPCB, Malaysia
  • Conference on Accreditation of Sites, Investigators and Ethics Committees
  • Free e-Course : Regulation on Medical Devices and Diagnostic Kits in India
  • Webinar on Clinical Trial Insurance in Current Perspective of Compensation Requirements in India

Tag Cloud

Approved Drugs Clinical Research Compensation Dcgi Drug Approved Drug List Fdcs Fixed Dose Combination Informed Consent Process Not Approved Webinar

Socialize with us!

  • Facebook
  • Google+
  • LinkedIn
  • Twitter

Signup for our mailing list!






Contact Us!

Auriga Research Pvt. Ltd. (A Contract Research Organization)
3/15 Kirti Nagar Industrial Area
New Delhi
India 110015
e-mail - [email protected]
Telephone - +91 11 45754546

Copyright © 2019 Auriga Research Pvt. Ltd.

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.